What is SYPR's health score?

SYPRIS SOLUTIONS INC (SYPR) has a TradeApes health score of 25 out of 100, rated Stressed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SYPR's estimated fair value?

Based on our 5-year discounted cash flow model, SYPRIS SOLUTIONS INC's estimated fair value is $0.25 per share, representing a -91.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is SYPR undervalued or overvalued?

Our model currently rates SYPR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SYPR... Refresh in a moment for the full analysis.

SYPRIS SOLUTIONS INC (SYPR)

Healthcare Overvalued low stressed

$2.88

Updated: 2026-06-06

TradeApes Score

Financial Strength

5 Stressed

Operating Trend

40 Weak

Relative Value

15 Stressed

Capital Allocation

45 Mixed

Risk

30 Weak

Est. Fair Value $0.25

DCF Upside -91.3%

Sector Rank #1916 of 6815

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.